|
-toxicology in Drug Discovery and Development. International Journal of Pharmacology, 9: 176-181.https://doi.org/10.3923/ijp.2013.176.181
Valerio, L.G. In silicotoxicology models and databases as FDA Critical Path Initiative toolkits. Hum Genomics 5, 200 (2011). https://doi.org/10.1186/1479-7364-5-3
|
|
|
toxicology
I. introduction
1. Health hazards
II. Gene mutation
1. Microbial Test in Vitro
2. Insects
3. Mammalian Cells in Culture
III. Chromosomal Effects
1. Cytogenetic Studies with Mammalian Cells (유전독성시험)
2. DNA repair and recombination
IV. Evaluation
1. Selection of Test S
|
|
|
in Toxicology
|
|
|
toxicology, and carcinogenicity in humans. Eur J Cancer 28:1182-1189, 1992 I. 서론
연구의 배경 및 목적
II. 내분비 교란물질이란?
1. 내분비 교란물질의 정의
2. 내분비 교란물질의 특성
3. 내분비 교란물질의 종류
III. 내분비 교란물질에 의한
|
|
|
Toxicology. The Basic Science of Poisons. 5th ed. New York, NY: McGraw-Hill, p. 813, (1995)
7) Oikawa H, Satomi M, Watabe S, Yano Y. Accumulation and depuration rates of paralytic shellfish poisoning toxins in the shore crab Telmessus acutidens by feeding toxic mussels under laboratory controlled co
|
|
메뉴펼치기
